Article Details

Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the ...

Retrieved on: 2021-03-03 15:00:00

Tags for this article:

Click the tags to see associated articles and topics

Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the .... View article details on hiswai:

Excerpt

Our aim is to translate discoveries and inventions into healthcare products and services that benefit patients and society. MSIP is accountable for the ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up